The formation of extracellular amyloid plaques is a common pathobiochemical event underlying several debilitating human conditions, including Alzheimer's disease (AD). Considerable evidence implies that AD damage arises primarily from small oligomeric amyloid forms of Aβ peptide, but the precise mechanism of pathogenicity remains to be established. Using a cell culture system that reproducibly leads to the formation of Alzheimer's Aβ amyloid plaques, we show here that the formation of a single amyloid plaque represents a template-dependent process that critically involves the presence of endocytosis-or phagocytosis-competent cells. Internalized Aβ peptide becomes sorted to multivesicular bodies where fibrils grow out, thus penetrating the vesicular membrane. Upon plaque formation, cells undergo cell death and intracellular amyloid structures become released into the extracellular space. These data imply a mechanism where the pathogenic activity of Aβ is attributed, at least in part, to intracellular aggregates.
Alzheimer | aggregation | neurodegeneration | prion | protein misfolding A myloid fibrils are fibrillar polypeptide aggregates consisting of a cross-β structure . A vast number of natural or nonnatural polypeptide chains have been reported to from amyloid fibrils (1, 3) . These fibrils relate structurally to the infectious prions from Creutzfeldt-Jakob disease (5) . In Alzheimer's disease (AD), amyloid fibrils are formed from Aβ peptide (6) . This peptide is produced at cholesterol-rich regions of neuronal membranes and secreted into the extracellular space (7) . Aβ peptide can vary in length. The 40-residue peptide Aβ represents the most abundant Aβ species in normal and AD brains, followed by the 42-residue peptide Aβ(1-42) (6) . Aβ and Aβ are able to adopt many differently shaped aggregates including amyloid fibrils (8) (9) (10) (11) as well as nonfibrillar aggregates that are sometimes termed also Aβ "oligomers" (12, 13) . It is not well established which Aβ state is most responsible for AD or why. Nor exists consensus on the precise subcellular location of Aβ pathogenicity. Aβ peptide and Aβ amyloid plaques typically occur outside the cell (14, 15) , but considerable evidence points towards a potential relevance of intracellular Aβ (16) (17) (18) (19) (20) .
To shed some light on the mechanism of Aβ aggregation and pathogenicity we here report a cell-culture model that faithfully enables analysis of the formation of amyloid plaques inside the culture dish. We show that living cells are critical for plaque formation and that plaque biogenesis involves Aβ accumulation within intracellular vesicles, such as multivesicular bodies (MVBs). The fibrils formed by Aβ under these conditions impair the ordered vesicular functions by growing out and penetrating the vesicular membrane. Ultimately, these events lead to the death of the affected cells and the extracellular accumulation of previously intracellular amyloid structures.
Results
Different Types of Cells Can Promote Amyloid Plaque Formation. Previous analyses suggested an implication of living cells in amyloid plaque formation from Aβ peptide (21) . To test this hypothesis, we examined different cell types for their potential plaque promoting activity. Analyzed cells include simian kidney cells (COS), human embryonic kidney-293 cells (HEK-293), human neuroblastoma cells (SH-SY5Y), laryngeal carcinoma cells (HEp-2), murine (J-774A.1), and human monocytic cells (THP-1). The latter were activated and differentiated into macrophages using phorbol 12-myristate 13-acetate. To induce plaque formation, freshly dissolved Aβ(1-40) peptide was added to the culture medium. Plaque formation was monitored either by using the filter retention assay (Fig. 1A) or Congo red (CR) green birefringence ( Fig. 1C-F and Fig. S1 ). The filter retention assay separates Aβ plaques from soluble Aβ by retention on a filter membrane. Immunological detection of Aβ allows semiquantitative read outs. CR green birefringence is an anisotropic optical effect of CRbound amyloid fibrils that can be visualized by polarizing microscopy. CR birefringence provides qualitative evidence for presence of amyloid-like cross-β structure. Filter retention shows plaque formation with all types of cells examined here (Fig. 1A) . Qualitatively similar results are obtained with CR green birefringence. Representative images for THP-1 cells are shown in Fig. 1C-F . In addition, we noted that presence of minute amounts of preformed Aβ(1-40) fibrils presents a seeding effect. It accelerates plaque formation (Fig. S2A ) and reduces the well-to-well variance.
Although different types of cells share a common ability to promote amyloid plaque formation, we note differences in the extent to which this reaction is supported by different cell lines. THP-1 and J-774A.1 cells show the strongest effects. These cell lines are highly endocytosis-or phagocytosis-competent and belong to the group of mononuclear phagocytes. Primary mononuclear phagocytes also enable Aβ plaque formation, as shown for murine microglia, murine macrophages, and human macrophages (Fig. S1 ). The lowest plaque yield is detected in cultures of SH-SY5Y neuroblastoma cells (Fig. 1A) . Plaque formation can be reduced by addition of the known amyloid inhibitor CR (Fig. S2B) or by replacing wild type Aβ with the Aβ variant Val18-Pro (Fig. S2C ) that possesses a low intrinsic aggregation propensity (22) . Effectively no discernible plaque formation is seen in the absence of cells or in the presence of dead cell bodies after paraformaldehyde (PFA) or methanol fixation (Fig. 1B) . Hence, living cells are required for plaque biogenesis ( Fig. 2A ). This conclusion is further corroborated by time-lapse video microscopy ( Fig. 2B ) that does not provide evidence for any cell-independent plaque nucleation or growth events. Instead, plaque formation occurs always in close spatial association with cells or within the cell bodies.
Based on their biochemical, biophysical, and tinctorial properties, resultant Aβ assemblies represent bona fide amyloid plaques. They produce CR green birefringence (Fig. 1C-F) . Aβ is retained by the filter retention assay (Fig. 1A) . Scanning electron microscopy (SEM) shows the extracellular localization and fibrillar constitution of the plaques (Fig. 1G) . Aβ immunogold labeling demonstrates that the fibrils are constructed from Aβ peptide (Fig. 1H-I ). Plaques stain intensively with Alcian blue, consistent with the presence of glycosaminoglycans (Fig. S3) . Light microscopy (Fig. 1C) and SEM (Fig. 1G ) reveals an infiltration of the plaques by THP-1 cells. Altogether these properties correspond closely to known hallmark characteristics of amyloid plaques in natural tissue deposits (23) . Time-lapse video microscopy analysis of Aβ plaque formation is based on promofluor-488 labeled Aβ(1-40), termed here 488 Aβ. 488 Aβ allows fluorescent visualization of plaque formation, whereas cellular changes were monitored with phase contrast microscopy ( Fig. 2B) . Quantification of the fluorescence intensity within the area of an emerging plaque demonstrates the presence of two well-resolved phases, termed lag phase and growth phase (Fig. 3 ). This type of kinetic behavior is highly characteristic for amyloid fibrillation reactions and indicates its nucleationdependence (24) . Although such biphasic growth profiles have been observed previously as bulk solution properties of whole samples or biological systems ( Fig. S4C) (21, 24, 25) , the present analysis demonstrates this type of kinetic behavior also at the level of a single amyloid plaque.
Analysis of time-lapse video microscopy images recorded during the lag phase shows only weak and dispersed fluorescence signals within the area of a prospective plaque (Fig. 2B, 33 h) . Onset of the growth phase is marked by the appearance of a single spot of bright fluorescence intensity, the plaque nucleus (Fig. 2B , 40 h). This spot continuously increases in fluorescence intensity during the growth phase, implying that Aβ peptide is continuously incorporated into the plaque. There has been no evidence for an influx of discrete fluorescence foci into the emerging plaque; therefore, plaques do not grow by clumping together preformed plaque-like structures. However, there were single observations of two independently nucleated plaque nuclei that eventually coalesce into a single common plaque.
Individual plaques from the same sample can show profound differences in their formation kinetics. These variations are evident from the different length of the lag phase, termed lag time. The lag time can vary for the analyzed culture from 18 to 51 h (Fig. 3) . A similar heterogeneity has been described previously for in vitro fibrillation reactions as well (24, 25) , or molecular dynamics simulations (26) . Such heterogeneity may arise from the stochastic nature of the nucleation reaction or from the formation of differently structured nuclei. Furthermore, the observed time frame of plaque growth resembles the time frame of Aβ plaque growth reported for transgenic AD mice (27) .
Support for the template-dependence of plaque formation comes from observations that preformed fibrils seed plaque formation in our system. Addition of preformed Aβ(1-40) fibrils seeds the formation of plaques (Fig. S4A) . Control reactions without cells show no significant plaque formation (Fig. S4B) . We have tested different amyloid fibrils that were prepared in vitro from different polypeptide chains with respect to their seeding efficiency. These fibrils were formed from Aβ and Aβ(1-42), transthyretin, murine serum amyloid A (mSAA) protein, insulin, glucagon, apomyoglobin, and a peptide corresponding to the G-helix of myoglobin. Thus, the analyzed fibrils include polypeptide sequences responsible for amyloid disorders, such as transthyretin or mSAA, whereas other polypeptide sequences are only known to form amyloid in vitro, such as the G-helix (1, 28, 29) . Measured seeding efficiencies are strictly template-dependent; hence, different fibrils differ considerably in their seeding efficiency (Fig. S4A) . Aβ fibrils tend to seed more efficiently than non-Aβ fibrils. Furthermore, Aβ(1-40) fibrils produce stronger effects than Aβ(1-42) fibrils which is consistent with previous observations (30) . The high seeding efficiency of Aβ-derived fibrils, consistent with concepts that emphasize the importance of sequential complementarity in amyloid formation (2) .
As a next step we have tested the seeding efficiency of various fibrils using an in vitro assay, where Aβ(1-40) fibrillation is monitored with thioflavin-T (ThT) fluorescence (Fig. S4C) . Analysis of lag times shows considerable variations for different seeds (Fig. S4D) . A short lag time means efficient nucleation, whereas a long lag time means inefficient nucleation (25) . The various seeds differ significantly in the efficiency by which they can promote the nucleation of Aβ(1-40) plaques in cell culture. The order of seeding activities seen within the in vitro fibrillation assay corresponds to the one observed in cell culture (Fig. S4A) . The correlation coefficient R of the two datasets is 0.74 (Fig. S4E) . We conclude that the seeding activity in THP-1 cell culture follows the intrinsic, biophysical propensity by which Aβ(1-40) peptide extends a given seed whereas cell-specific processes, such as differences in the processing or transport of the various seeds, are not required to explain the encountered differences.
Extracellular Aβ Plaques are Preceded by Intracellular Intermediates.
In accord with our above observations that living cells are relevant for plaque formation, we find that impairment of cellular functions with cytochalasin B (Cyt) or latrunculin B (Lat) potently reduces the plaque yield (Fig. 4A) . Control experiments show that the reduced plaque formation cannot be explained by a direct antiamyloidotic activity of the two agents or by their potential cytotoxicity. Cyt and Lat do not affect the fibril nucleation kinetics, as shown by an indistinguishable lag time with or without Cyt or Lat (Fig. 4B) . They do not alter the fibril elongation kinetics, measurable from the growth rate (Fig. S5A) , or the fibril yield, as determined from the pellet fraction after centrifugation (Fig. S5B) . Furthermore, cell viability measurements carried out by using the lactate dehydrogenase assay do not show any discernible cytotoxic effect of the two agents (Fig. 4C) . However, cell viability measurements carried out in the absence of Lat or Cyt show that the process of Aβ amyloid plaque formation itself is detrimental to THP-1 cells (Fig. 4D) .
Given that Cyt and Lat are known inhibitors of endo-and phagocytosis reactions these data imply that plaque formation might require, at least transiently, the internalization of Aβ peptide. Support for this notion comes from confocal-like fluorescence microscopy (CFM) and transmission electron microscopy (TEM). The two techniques consistently show intracellular Aβ peptide structures prior to plaque formation or cell death. CFM shows that Aβ uptake commences within 5 min after addition of the peptide to the culture medium (Fig. S6) . Internalized Aβ occurs in the form of discrete and relatively small-sized fluorescent spots (Fig. S6) , consistent with its intravesicular localization. A significant fraction of the internalized peptide shows colocalization with Alexa Fluor 555-conjugated transferrin ( 555 TF), a marker of clathrin-dependent endocytosis (Fig. S6) . Hence, THP-1 cells internalize Aβ peptide partly through this pathway. THP-1 cells differ in this property from cultured neurons that show only very little, if any, Aβ uptake by clathrindependent endocytosis (31) . Consistent with the relevance of Aβ internalization, SH-SY5Y neuroblastoma cells are found here to possess a relatively low plaque-promoting activity (Fig. 1A) . Control experiments with compartment markers for Golgi apparatus (giantin) or endoplasmic reticulum (calnexin) do not show colocalization with 488 Aβ. CFM could not detect significant colocalization between internalized 488 Aβ and markers for early endosomes or lysosomes, including lysosomal-associated membrane protein 2, rhodamine-dextrane and Lyso Tracker (Figs. S6, S7 ). In addition, cell freeze fracturing coupled with Aβ immunogold labeling and TEM analysis was unable to observe substantial levels of Aβ within small unilaminar vesicles, such as endosomes or lysosomes. The low colocalization efficiency with lysosomal markers implies a low concentration of Aβ in this compartment. Possible explanations hereof include retention in other compartments or prelysosomal degradation.
Interestingly, TEM analysis reproducibly demonstrates Aβ within MVBs (Fig. 5, Fig. S8 ). MVBs represent multifunctional compartments that functionally interact with other vesicular pathways (32) ; and this central vesicular compartment appears to be primarily affected by the action of Aβ peptide. MVBs do not only engulf Aβ peptide within their lumen. Several TEM images show bundles of Aβ fibrils that penetrate the vesicular membrane and extend into the cytoplasm (Fig. 5, Fig. S8 ). In some cases there was also evidence for a deformation of the MVB shape, possibly arising from their stiff, fibrillar content (Fig. S8) . These abnormalities are seen within cells that appear by all other morphological means intact and viable, indicating the encountered Aβ-induced disturbances of MVB function precede cell death.
Discussion
The presented data imply a mechanism for the formation of Aβ amyloid plaques in which initially soluble and extracellular Aβ peptide becomes internalized and sorted into MVBs. Upon spontaneous nucleation or in the presence of suitable fibril seeds, fibrils grow out, disturb the ordered MVB function and penetrate the vesicular membrane. Ultimately cells die and all intracellular structures, including all intracellular amyloid species, become released into the extracellular space.
This mechanism is consistent with substantial evidence from AD brain tissues and AD animal models. Specifically, it reconciles the known extracellular deposition of terminal amyloid plaques in AD patients or AD mouse models (15, 23) with numerous observations from AD patients (33) , AD mouse models (34) and Aβ-transgenic Drosophila melanogaster flies (35) showing that Aβ species may also accumulate inside the cell, including MVBs (16, 36, 37) , lysosomes or other vesicular compartments (38) (39) (40) . The present observation of an intracellular route of amyloid plaque formation is consistent with observations that extracellular amyloid plaques typically contain a spectrum of proteins that are originally intracellular. For instance, AD plaques commonly contain lysosomal proteases or molecular chaperones from the heat shock protein families Hsp70 or Hsp20 (17, 36, (41) (42) (43) .
It is important to emphasize, however, that the cell death seen in our cell-culture system represents the cell death associated with plaque biogenesis. This cell death needs not be the same as the one responsible for the massive neuronal loss in AD patients. Neuronal loss has been shown not to correlate well with plaque formation in AD patients (44) and also AD mouse models can present tremendous plaque loads despite very little neuronal death (45) . A possible explanation for these in vivo observations is provided by our present data showing that different types of cells are evidently able to promote plaque formation (Fig. 1A) .
Although the cells responsible for in vivo plaque formation remain to be established, we show here that different types of cells possess the general ability to promote this reaction. Hence, amyloid plaque formation in vivo needs not to depend on or affect primarily the neuronal cells. Out of all tested cells we find that SH-SY5Y human neuroblastoma cells yield the lowest plaque levels (Fig. 1A) . Previous analyses of human AD samples or animals imply the involvement of various types of cells, including neurons (46) , astrocytes (47) , smooth muscle cells (48) , microglia or other mononuclear phagocytes (49, 50) .
The role of mononuclear phagocytes remains particularly controversial. Although these cells seem important for amyloid plaque biogenesis in some extracerebral amyloidoses (51) (52) (53) , their net physiological role in AD may rather be plaque clearance (54) . Here, we use these cells because of their relatively high plaque-promoting activity. Nevertheless, we suggest that, despite the relatively general ability of cells to promote plaque formation, in vivo plaque formation may well involve only some cell types. However, their involvement will depend rather on other specific cellular properties such as migration behavior or endocytotic activity along with the precise and tissue-dependent conditions of Aβ exposure such as local Aβ concentrations or effective exposure times.
Regarding the role of Aβ internalization it is possible to explain the need of these reactions for plaque biogenesis with several observations. For instance, internalization increases the local Aβ concentration and restricts the peptide within a confined space. This situation is known to favor intermolecular aggregation reactions of amyloid fibril formation (55, 56) . In addition, internalization exposes Aβ peptide to factors that are known to promote its fibrillation, such as the ganglioside GM1 (57) . And indeed, GM1 has been reported to occur of the inside of several vesicular membranes (58) .
Support for the notion that Aβ-internalization by nonneuronal cells represents a possible pathway toward Aβ aggregation comes also from observations that neuronal expression of Aβ in transgenic animals produces intravesicular Aβ aggregates within neighboring glia cells (59) . Evidently, these glia cells must have internalized the Aβ peptide that was secreted initially from adjacent neuronal cells.
The current data are also relevant in the context of previous proposals suggesting that cytoplasmatic Aβ is key to Aβ pathogenicity (19) . However, it has remained largely unclear how Aβ peptide, which occurs typically within extracellular compartments may transit into the cytoplasm. Using immunogold labeling combined with cell freeze-fracturing and EM we here show the penetration of MVB membranes and the translocation of a certain proportion of Aβ peptide into the cytoplasm (Fig. 5, Fig. S8 ). Therefore, our observations provide a direct link between the normal localization of Aβ peptide within extracellular space or vesicular compartments and a translocation into the cytoplasm in the course of cell death. Moreover, there has been previous evidence that the loss of the integrity of endosomal/lysosomal membranes represents an early event of Aβ pathogenesis (60) and it was suggested that the leakage of intracellular vesicles may lead to Aβ-dependent cell death (60) . Further work will be required to ascertain whether or not these pathways are responsible for the encountered cell death in our model system as well. As pointed out above there may be more than one route of Aβ to pathogenicity and the precise processes responsible for the neuronal loss of AD patients remain to be established. Several studies have suggested an implication of nonfibrillar Aβ aggregates, sometimes termed oligomers.
The present characterization of different types of cells, all able to promote the formation of Aβ plaques in cell-culture, provides a solid basis for designing further experiments that scrutinize the mechanism of AD plaque formation in cell culture or within native brain tissues. A better understanding of these steps will also pave the way for targeting the earliest steps of plaque formation with conformation-specific antibodies (13, 61) or with small molecules that redirect aggregation pathways into a more favorable direction (62) .
Materials and Methods
Th-T Aggregation Kinetics Measurements. Unless indicated otherwise, samples contained 50 μM Aβ(1-40) in 100 μL, 50 mM Hepes buffer, pH 7.4, 20 μM ThT, 10 mM sodium azide with or without 0.1 μg seeds. Instrumental settings were used as described (63) .
Amyloid Plaque Formation in Cell Culture. Plaque formation was induced by supplementing the culture medium with freshly dissolved Aβ(1-40) peptide (final concentration in the well: 60 μg/mL). Immediately before Aβ was added to the medium, lyophilized, recombinant Aβ(1-40) peptide was dissolved at 10 mg/mL concentration in double-distilled water, sonicated for 2 min, followed by centrifugation for 15 min (10; 500 × g). Freshly dissolved Aβ was replenished each time the culture medium was replaced. In some experiments the medium was additionally supplemented with seeds (see SI Text for details on cell culture and sample seeding).
Light Microscopy. Time-lapse fluorescence and phase contrast images were recorded at 10 min intervals with a CCD-camera (Axiocam MRm, Zeiss). Data analysis was performed with Zeiss software (AxioVs40 V4.5). Confocal (Zeiss LSM510) and confocal-like (Zeiss Axiovert 200 Apotome) fluorescence microscopy were recorded with cells that were either immuno-stained or exposed to fluorescent particles (see SI Text for details).
Electron Microscopy. Scanning electron microscopy was performed at a FE-SEM, LEO 1530 Gemini instrument whereas transmission images were viewed with an EM902A transmission electron microscope (Zeiss). For freezefracture replica immunogold labeling samples were fractured and replicated in a BAF400T (BAL-TEC) freeze-fracture unit at −150°C using a double-replica stage. The replica immunogold labeling was performed using an Aβ (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) antibody diluted 1∶25 and a 1∶50 diluted second goat antimouse antibody coupled with 10 nm gold (British Biocell International). Other sample work up details are described in SI Text.
Statistical Analysis. Errors or error bars represent the standard deviation. Significance (*) was established with an unpaired t-test up to a level of p ¼ 0.05.
